Cancer Pharmacology and Experimental Therapeutics
Sloan Kettering Institute is seeking innovative individuals who wish to address problems of relevance to cancer pharmacology including discovery and mechanistic studies of small molecules or biologics, synthetic biology or cellular therapies, or genetic therapies, for a tenure-track position at the Assistant or Associate Member level with strong research accomplishments in biology, biochemistry or pharmacology. Faculty will be eligible to hold graduate school appointments in the Gerstner Sloan Kettering Graduate School of Biomedical Sciences, the Weill Graduate School of Medical Sciences of Cornell University, as well as the Tri-Institutional MD/PhD Training Program and Tri-Institutional Training Program in Chemical Biology.
MSK offers a unique and exciting research environment with programs in Immunology, Pharmacology, Chemistry, Molecular Biology, Computational Biology, Genetics, Cell Biology, Developmental Biology, Cellular Biochemistry and Structural Biology. The presence of world-renowned clinical programs in cancer research, treatment and prevention offers unique opportunities for creative collaboration.
Applicants should have a PhD and/or MD degree, postdoctoral experience, and dedication to important problems at the interface of biology, biochemistry or chemistry as they relate to cancer pharmacology or innovative therapeutics.
The deadline for applications is October 17, 2022. Interested candidates should visit https://facultysearch.ski.edu to access the on-line faculty application. Please visit the site as soon as possible, as it contains important information on the required application materials, including deadlines for submission of letters of reference.
Inquiries may be sent to Katrina Panganiban at email@example.com.
MSK is an equal opportunity and affirmative action employer committed to diversity and inclusion in all aspects of recruiting and employment. Women and minority candidates are strongly encouraged to apply.